Print Page | Contact Us
Online Store: Environmental Medicine Training
Main Storefront
        

TACT Trial: Efficacy of EDTA Chelation in Cardiovascular Disease

Item Options
Sign in for your pricing!
Price: $29.00
Quantity: *
 
Description

Webinar #9 of 23 in the Environmental Medicine Training Series

TACT Trial: Efficacy of EDTA Chelation in Cardiovascular Disease

At the conclusion of this educational activity, participants will be able to:

 

  1. Apply knowledge based on TACT trial outcomes when assessing treatment for cardiovascular disease in those with prior myocardial infarctions in order to decrease risk for further events in these patients

 

Original Air Date: November 3, 2014

Approved for:
1.00
 General Credit Hours by the  Oregon Board of Naturopathic Medicine


Gervasio Lamas, MD

Dr. Lamas is the Chairman of Medicine at Mount Sinai Medical Center and Chief of the Columbia University Division of Cardiology at Mount Sinai Medical Center. He received his B.A. in Biochemical Sciences cum laude from Harvard College and his M.D. with honors (AOA) from New York University. He completed his Internship and Residency at the Brigham and Women's Hospital of Harvard Medical School, where he later served as Assistant Professor of Medicine. Dr. Lamas relocated to South Florida in 1993, when he became Chief of Cardiology at Mount Sinai and later served as the hospital's Director of Cardiovascular Research and Academic Affairs. From June of 2008 until January 2009, he was Director of the Cardiology Fellowship Program at Jackson Memorial Hospital/ VAMC/University of Miami, Director of the U.M. Hospital Coronary Care Unit, and Interim Vice Chair of Clinical Affairs at the U.M. Miller School of Medicine Division of Cardiology. During the last decade, he has enrolled thousands of patients in more than a dozen U.S. and international trials in order to improve cardiac care and prevent death and disability from heart disease. He served as Chairman of the Mode Selection Trial in Sinus Node Dysfunction (MOST), a trial that revolutionized cardiac pacemakers. He presently serves as Co-Chairman for the Occluded Artery Trial (OAT), and Study Chair for the Trial to Assess Chelation Therapy (TACT), a $30 million trial sponsored by the National Institutes of Health. He has authored over 300 scientific publications, and maintains an active clinical practice in Miami Beach and Key Biscayne. 


Purchase Includes:

  • Lecture slides and handouts (if applicable) are yours to keep
  • CE Certificate - 1.00 General Credit Hours by the Oregon Board of Naturopathic Medicine (OBNM)